FUJISAWA USA, INC., FUJISAWA PHARMACEUTICAL CO -- EPINEPHRINE INJECTION -- 6505-01-289-2008 
=====================  Product Identification  =====================

Product ID:EPINEPHRINE INJECTION
MSDS Date:10/07/1992
FSC:6505
NIIN:01-289-2008
=== Responsible Party ===
Company Name:FUJISAWA USA, INC., FUJISAWA PHARMACEUTICAL CO
Address:3 PARKWAY NORTH
City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Info Phone Num:708-317-0800
Emergency Phone Num:800-888-7704
CAGE:0K706
=== Contractor Identification ===
Company Name:FUJISAWA USA, INC
Address:3 PKY N
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:847-317-1256
CAGE:39832
Company Name:FUJISAWA USA, INC.
Address:3 PARKWAY NORTH
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:708-317-0800 OR 800-888-7704
CAGE:0K706

=============  Composition/Information on Ingredients  =============

Ingred Name:EPINEPHRINE  (SARA III)
CAS:51-43-4
RTECS #:DO2625000
Fraction by Wt: 0.01%
Other REC Limits:NONE RECOMMENDED
EPA Rpt Qty:1000 LBS
DOT Rpt Qty:1000 LBS

Ingred Name:SODIUM CHLORIDE
CAS:7647-14-5
RTECS #:VZ4725000
Fraction by Wt: 0.816%
Other REC Limits:NONE RECOMMENDED

Ingred Name:SODIUM METABISULFITE
CAS:7681-57-4
RTECS #:UX8225000
Fraction by Wt: 0.05%
Other REC Limits:NONE RECOMMENDED
OSHA PEL:5 MG/M3
ACGIH TLV:5 MG/M3; 9293

Ingred Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
Other REC Limits:NONE RECOMMENDED

Ingred Name:NOTE: PH ADJUSTED WITH CITIRIC ACID AND SODIUM CITRATE.
RTECS #:9999999ZZ
Other REC Limits:NONE RECOMMENDED

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50 (ORAL, RAT) IS  UNKNOWN.
Routes of Entry: Inhalation:NO	Skin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:ACUTE- THIS PRODUCT IS INTENDED FOR
    THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A PHYSICIAN. POTENTIAL
    ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
    PRESCRIBED IN THE PACKAGE INSERT. OCCUPATIO NAL EXPOSURE HAS NOT
    BEEN FULLY INVESTIGATED. CHRONIC- NOT KNOWN
Effects of Overexposure:EYE, SKIN AND RESPIRATORY TRACT IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN DISORDERS MAY BE
    MORE SUSCEPTIBLE TO THIS MATERIAL.

=======================  First Aid Measures  =======================

First Aid:CONSULT PHYSICIAN IF SYMPTOMS PERSIST. EYE/SKIN:FLUSH WITH
    WATER FOR 15 MINUTES. HOLD EYELIDS OPEN. INHALATION:REMOVE TO FRESH
    AIR. PROVIDE CPR/OXYGEN IF NEEDED. INGESTION:FLUSH MOUTH OUT WITH
    WATER I MMEDIATELY. SEEK MEDICAL ATTENTION.

=====================  Fire Fighting Measures  =====================

Flash Point Method:CC
Flash Point:>200F,>93C
Extinguishing Media:WATER FOG, CARBON DIOXIDE, FOAM OR DRY CHEMICAL.
    WATER SPRAY MAY BE USED TO KEEP FIRE EXPOSED CONTAINERS COOL.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
    SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:MAY EMIT TOXIC FUMES OF NOX.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT. USE ABSORBENT
    TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE SURFACES CLEAN AND WASH
    WITH SOAP AND WATER.
Neutralizing Agent:WEAK BASE

======================	Handling and Storage  ======================

Handling and Storage Precautions:AS A GENERAL RULE, WHEN HANDLING
    PHARMACEUTICAL PRODUCTS, AVOID ALL CONTACT AND INHALATION OF DUST,
    FUME, MISTS AND/OR VAPORS ASSOCIATED WITH PRODUCT.
Other Precautions:KEEP OUT OF REACH OF CHILDREN.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
    PROTECTION NOT USUALLY REQUIRED.
Ventilation:MECHANICAL (GENERAL) ROOM VENTILATION IS USUALLY
    SATISFACTORY. USE LOCAL EXHAUST VENTILATION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX RECOMMENDED
Eye Protection:SAFETY GOGGLES/GLASSES RECOMMENDED
Other Protective Equipment:EYE WASH STATION, DISPOSABLE GARMENTS IF
    DIRECT CONTACT IS ANTICIPATED.
Work Hygienic Practices:PRACTICE GOOD HYGIENIC PROCEDURE.
Supplemental Safety and Health
FLASH POINT IS ESTIMATED.

==================  Physical/Chemical Properties  ==================

HCC:C3
Boiling Pt:B.P. Text:NOT KNOWN
Melt/Freeze Pt:M.P/F.P Text:NOT KNOWN
Vapor Pres:NOT KNOWN
Vapor Density:6.31
Spec Gravity:NOT KNOWN
pH:2.2-5
Evaporation Rate & Reference:NOT KNOWN
Solubility in Water:SLIGHTLY SOLUBLE
Appearance and Odor:CLEAR, COLORLESS, ODORLESS SOLUTION

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
STRONG BASES
Stability Condition to Avoid:EXPOSURE TO LIGHT MAY CAUSE DECOMPOSITION.
Hazardous Decomposition Products:MAY EMIT TOXIC FUMES OF NOX.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
    AND FEDERAL REGULATIONS.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.